Back to Centiva Capital, LP Centiva Capital, LP

REGNREGN
25 quarters

Position history for Centiva Capital, LPCentiva Capital, LP's holdings in REGENERON PHARMACEUTICALS

Yes. Centiva Capital holds 408 shares of REGN (Regeneron Pharmaceuticals), worth $254,404, as of its Q2 2026 13F filing. It reduced the position by 14,202 shares (-97.2%) from Q1 2026. Centiva Capital has held REGN since Q1 2026, across 2 quarterly 13F filings.

Current Value

$254,404

Current Shares

408

Total Value Change

-$2.3M

Total Shares Change

-5,925

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
408
-97.2%
$254,4040.0%$622.81
0
2026-Q1
New
14,610
-
$11.3M0.1%$770.59
38
2025-Q3
Exited
0
-100.0%
$00.0%$559.40
0
2025-Q2
New
431
-
$226,2750.0%$521.53
32
2025-Q1
Exited
0
-100.0%
$00.0%$629.11
0
2024-Q4
New
604
-
$430,2470.0%$705.67
33
2024-Q3
Exited
0
-100.0%
$00.0%$1,041.41
0
2024-Q2
Decreased
66
-86.5%
$69,3680.0%$1,041.20
0
2024-Q1
Increased
487
+1703.7%
$468,7330.0%$953.49
39
2023-Q4
Decreased
27
-98.1%
$23,7140.0%$870.08
0
2023-Q3
New
1,407
-
$1.2M0.0%$815.27
35
2023-Q1
Exited
0
-100.0%
$00.0%$813.99
0
2022-Q4
Increased
1,016
+238.7%
$733,0340.0%$714.75
40
2022-Q3
Decreased
300
-91.6%
$207,0000.0%$682.43
0
2022-Q2
Increased
3,571
+47.0%
$2.1M0.1%$585.60
35
2022-Q1
New
2,430
-
$1.7M0.0%$691.89
36
2021-Q4
Exited
0
-100.0%
$00.0%$625.62
0
2021-Q3
Decreased
749
-74.0%
$454,0000.0%$599.52
0
2021-Q2
Increased
2,884
+18.6%
$1.6M0.0%$553.32
30
2021-Q1
New
2,432
-
$1.2M0.0%$468.72
35
2020-Q1
Exited
0
-100.0%
$00.0%$483.73
0
2019-Q4
New
1,466
-
$550,0000.0%$371.97
34
2019-Q3
Exited
0
-100.0%
$00.0%$274.81
0
2019-Q2
Decreased
558
-91.2%
$175,0000.0%$310.07
0
2019-Q1
First report
6,333
-
$2.6M0.2%$406.78
0

Other major holders of REGN: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used